Global Health

Shared Value in Emerging Markets

Greg Hills, Patty Russell, Veronica Borgonovi, Alex Doty, Lakshmi Iyer

Innovative business strategies can create sustainable impact at scale for poor or vulnerable individuals.

Report

Boosting the Immunization Workforce: Lessons from the Merck Vaccine Network - Africa

Leigh Fiske, Amanda Rinderle, Greg Hills

Lessons for the field from ten years of immunization workforce training in Africa.

Report

Private Enterprise for Public Health: Opportunities for Business to Improve Women's and Children's Health

A guide for how companies can create shared value in women's and children's health.

Report

What Is Collective Impact?

This series of short videos describes the concept of collective impact, and shows the 5 conditions of collective impact in action using The Elizabeth River Project and The Global Alliance for Improved Nutrition (GAIN) as examples.

Video

Executive Insights with Gary M. Cohen

Gary M. Cohen, Executive Vice President at BD discusses creating shared value in global health at the "Competing to Save Lives" conference.

Video

Executive Insights with Michael J. Warmuth

Michael J. Warmuth, Senior Vice President, Established Pharmaceuticals at Abbott discusses creating shared value in global health at the "Competing to Save Lives" conference.

Video

Executive Insights with Anuj Pasrija

Anuj Pasrija, Head, Social Business, Group Emerging Markets, Novartis discusses creating shared value in global health at the "Competing to Save Lives" conference.

Video

Competing by Saving Lives

Kyle Peterson, Matthew Rehrig, Mike Stamp, Samuel Kim

How pharmaceutical and medical device companies create shared value in global health.

Report

Webinar

Creating Shared Value in India

Veronica Borgonovi, Simon Meier, Manjari Sharda, Lalitha Vaidyanathan

“Creating shared value” is gaining traction worldwide; examine how companies in India are contributing to inclusive growth – and gaining competitive advantage.

Report

Executive Summary

Water Access, Sanitation, and Hygiene (WASH): U.S. Advocacy Landscape

Mark Kramer, Jennifer Splansky, Jason Lee, Megumi Tsutsui, Matt Wilka

This research summarizes the U.S. advocacy landscape for global access to clean water, sanitation, and hygiene, and suggests goals to drive future advocacy.

Report

PDP Access Strategies

Laura Herman, Amanda Oudin

This report highlights the current status of PDP access strategies, select access strategy challenges, and future considerations for improving access strategies

Report

Mobilizing Resources for the Human Rights of Lesbian, Gay, Bisexual and Transgender People

Marcie Parkhurst, Amber Johnson

By surfacing approaches to mitigating funding obstacles, this report is a call to action to mobilize funding for LGBT efforts.

Report

Smarter Programming of the Female Condom

FSG, with Elliot Marseille and James G. Kahn

New research examines how the female condom fits within HIV prevention and makes recommendations for increasing its impact and cost-effectiveness.

Report

Diarrheal Disease Advocacy: Findings from a Scan of the Global Funding and Policy Landscape

Laura Herman, Leigh Fiske, Jennifer Splansky, Kate Tallant

New funding and policy research for Path, a global nonprofit, informs their advocacy strategy around diarrheal disease in children.

Report

Toward a New Approach to Product Development Partnership (PDP) Performance Measurement

Kyle Peterson, Marc Pfitzer, Laura Herman, Patty Russell, David Zapol, Mike Stamp

This report highlights new approaches to measuring the performance of product development partnerships, multi-sector collaborations developing products for neglected diseases.

Report

Beyond R&D: Leveraging the Pharmaceutical Industry on Issues of Drug Access

Kyle Peterson, Fay Hanleybrown, Laura Herman

This report investigates whether and how pharmaceutical companies’ "downstream" assets and capabilities could be harnessed to improve access to existing and future drugs for neglected diseases.

Report

Social Investment Trends in the Pharmaceutical Industry

Kyle Peterson, Laura Herman

FSG analyzed trends in pharmaceutical philanthropy to understand how a select group of pharmaceutical companies creates value for society and their businesses through their philanthropic investments.

Report

When Success is Only an Intermediate Goal

Kyle Peterson, Laura Herman, Matthew Clark

This article describes FSG’s work with Medicines for Malaria Ventures (MMV), which led to a broadened definition of success, a deepened perspective on MMV’s core mission, and new approach to performance management. 

Report